Sorry CME is not currently available for this activity.

Interventional Cardiology in 2012 and Beyond


Mun K. Hong, MD, Director of Interventional Cardiology at St. Luke’s and Roosevelt Hospitals, discusses present and future percutaneous therapies for aortic valve stenosis, mitral valve regurgitation and coronary artery disease, and the results of research trials related to these therapeutic options.

Target Audience

Primary care physicians and cardiologists who wish to learn more about non-surgical options for aortic valve stenosis and coronary artery disease.

Objectives

• To provide an update on the recent developments in interventional cardiology
• To discuss potential future percutaneous therapeutic options in patients with cardiovascular disease

Accreditation Statement

Beth Israel Medical Center and St. Luke’s and Roosevelt Hospitals are accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

St. Luke’s and Roosevelt Hospitals designate this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure

It is the policy of Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. Beth Israel Medical Center and St. Luke's and Roosevelt Hospitals have established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following have reported that they do not have any financial relationships to disclose:
Mun K. Hong, MD

Presenter

Mun K. Hong, MD

Mun K. Hong, MD Mun K. Hong, MD, is the Director of Interventional Cardiology at St. Luke’s and Roosevelt Hospitals and is also Director of its cardiac catheterization lab.
View Full Profile